I initiate coverage on Merck & Co., Inc. with a Strong Buy rating and a $139 price target, driven by resilient execution and robust product depth. Merck is growing pharma sales and expanding ...

Despite mixed performance, Merck's stock has dropped 37% since mid-2024, but I maintain a buy rating due to long-term support and potential growth drivers. Merck's Q4 results beat expectations ...

The interim results of a phase 3 trial of Merck’s pulmonary arterial hypertension (PAH) treatment Winrevair were so conclusive that the company not only halted the study for efficacy ...

Let's take a look at what these Wall Street heavyweights have to say about Merck (MRK) before we discuss the reliability of brokerage recommendations and how to use them to your advantage.

Merck MRK announced that the FDA has accepted its regulatory filing seeking approval for the subcutaneous (under the skin or SC) formulation of the blockbuster drug Keytruda (pembrolizumab).

Merck MRK is a healthcare company that manufactures pharmaceutical products to treat various conditions in many therapeutic areas, including cardiometabolic disease, cancer and infections. Don't ...

The England and Wales appeals court handed down its judgment just seven working days after hearing the trademark dispute involving pharma company Merck The England and Wales Court of Appeal made light ...

Trodelvy + Keytruda improved progression-free survival over chemo + Keytruda in PD-L1+ metastatic TNBC. No new safety signals reported in ASCENT-04; overall survival trends will be tracked with ...

Winners of Merck Foundation "More Than a Mother" Media Recognition Awards 2024 Here are the winners from West African Countries in partnership with The First Lady of the Republic of The Gambia, H ...

Pharmaceutical companies including Pfizer, Merck, Johnson & Johnson and Bayer each gave $1 million to the inaugural committee for Trump and Vice President JD Vance, according to a filing with the ...